Document Detail


Maternal, umbilical, and amniotic fluid concentrations of tryptophan and kynurenine after labor or cesarean section.
MedLine Citation:
PMID:  9727715     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A major route of tryptophan metabolism is via the hepatic and cerebral synthesis of kynurenine, a substance subsequently used by astrocytes in the brain for the production of the neuroactive substances kynurenic acid and quinolinic acid. Both kynurenic and quinolinic acids have been implicated in modulating the activity of excitatory amino acid pathways in the brain, the former as a neuroprotectant because of its antagonist properties, and the latter as an excitotoxin because of its agonist actions, at NMDA receptors. We therefore determined the concentrations of tryptophan and kynurenine in maternal venous and umbilical cord blood, and in amniotic fluid, of infants after labor and vaginal delivery, and after delivery by cesarean section. Concentrations of tryptophan and kynurenine were significantly higher in umbilical vein plasma compared with maternal venous plasma. Tryptophan and kynurenine concentrations in umbilical vein plasma and amniotic fluid were significantly higher after labor, compared with samples obtained from infants of the same gestational age delivered by cesarean section. There was no umbilical vein-to-artery concentration difference for kynurenine in samples obtained after either labor or cesarean section, but there was a significant gradient for tryptophan in samples obtained after vaginal delivery, indicating increased transfer of this amino acid during labor. There was a significant correlation between umbilical vein tryptophan and kynurenine concentrations for both the labor and cesarean section groups, and plasma kynurenine concentrations were also significantly correlated with both umbilical vein cortisol concentrations and the duration of the second stage of labor in the vaginally delivered infants. These results suggest that the placental transfer of tryptophan and the fetal synthesis of kynurenine are increased during labor. These findings have implications for understanding the vulnerability of the infant brain to ischemic/hypoxic damage in the perinatal period. By analogy with the adult brain, the molar ratio of these substances is likely to determine the susceptibility of the brain to seizure and excitotoxic damage.
Authors:
H Kazda; N Taylor; D Healy; D Walker
Related Documents :
3826215 - Symphysis-fundus height, maternal height, labor pattern, and mode of delivery.
16125045 - Magnesium sulfate: the first-line tocolytic.
7395935 - Infants of mothers treated with ethanol for premature labor.
8796775 - Influence of intravenous fentanyl on fetal biophysical parameters during labor.
8847295 - Erythropoietin pharmacokinetics in premature infants: developmental, nonlinearity, and ...
3068655 - Pityriasis (tinea) versicolor in infancy.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Pediatric research     Volume:  44     ISSN:  0031-3998     ISO Abbreviation:  Pediatr. Res.     Publication Date:  1998 Sep 
Date Detail:
Created Date:  1998-11-24     Completed Date:  1998-11-24     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0100714     Medline TA:  Pediatr Res     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  368-73     Citation Subset:  IM    
Affiliation:
Department of Physiology, Monash University, Clayton, Victoria, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Amniotic Fluid / metabolism*
Cesarean Section*
Female
Fetal Blood / metabolism*
Humans
Kynurenine / blood*
Pregnancy
Tryptophan / blood*
Chemical
Reg. No./Substance:
343-65-7/Kynurenine; 73-22-3/Tryptophan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Exhaled isoprene and acetone in newborn infants and in children with diabetes mellitus.
Next Document:  Intrauterine growth retardation: evidence for the activation of the insulin-like growth factor (IGF)...